Skip to main content

Best Telehealth Services That Accept Insurance for GLP-1

Insurance can reduce GLP-1 medication costs from $1,300+/month to under $50. But not every telehealth service bills insurance or helps with prior authorization. Here's how to find the right one.

GLP-1 medications like Wegovy and Zepbound are now covered by most major insurance plans — Medicare Part D, roughly 60% of large employer commercial plans, and a growing number of state Medicaid programs. The challenge isn't whether coverage exists, but whether your telehealth provider knows how to unlock it.

The gap between a provider that handles prior authorization well and one that doesn't can be the difference between a $25 copay and a $1,349 retail bill. We evaluated telehealth services on insurance acceptance, prior-auth support, clinical documentation quality, and total patient cost with coverage.

GLP-1 Insurance Coverage at a Glance (2026)

MedicationMedicare Part DCommercial PlansPrior Auth Required?
Wegovy (semaglutide)Yes — obesity indication~60% of plansAlmost always
Zepbound (tirzepatide)Yes — obesity indication~45% of plansAlmost always
Mounjaro (tirzepatide)Yes — diabetes indicationWide coverageVaries
Ozempic (semaglutide)Yes — diabetes indicationWide coverageVaries
Compounded semaglutideNot coveredNot coveredN/A

Insurance covers brand-name FDA-approved medications only. Compounded versions are never eligible for insurance reimbursement.

What Makes a Telehealth Service Good for Insured GLP-1 Access?

Prior Auth Support

The best services submit prior authorization on your behalf, handle appeals when denied, and provide step therapy documentation. This is the single biggest factor in getting coverage approved.

Direct Insurance Billing

Services that bill your insurer directly save you from filing claims yourself. Look for platforms that accept your specific plan — not just 'insurance accepted' in general terms.

Obesity Medicine Specialists

Board-certified obesity medicine providers produce clinical documentation that insurers approve at higher rates. General practitioners may not know the specific language insurers require.

Formulary Awareness

Your insurance plan may cover Wegovy but not Zepbound, or vice versa. A good telehealth service checks your formulary and prescribes the medication most likely to be covered.

Transparent Membership Fees

Even with insurance covering medication, most services charge a monthly membership ($0–$249/month). Understand what the fee covers and whether it's worth it for your insurance situation.

Medicare Experience

Medicare prior authorization has specific documentation requirements. If you're on Medicare, choose a service with demonstrated experience navigating Part D coverage for obesity indications.

Telehealth Services Compared for Insurance

ServiceMonthly FeePA SupportBest For
Sequence$99/moDedicated team + appealsFull insurance navigation
FORM Health$199–$399/moSpecialist documentationComplex insurance cases
PlushCare$19.99/moStandardEasy-approval plans
Calibrate$249/moMedicare-specificMedicare patients
FoundFrom $99/moBasicBroad plan acceptance

Monthly fees are for the telehealth membership — medication costs are billed separately through your insurance. See full rankings and scores →

How to Get Your GLP-1 Covered Through Telehealth

  1. 1

    Check your formulary

    Call the number on the back of your insurance card or log into your plan portal. Search for Wegovy, Zepbound, Mounjaro, or Ozempic. Note which medications are covered and what tier they're on.

  2. 2

    Choose a telehealth service that bills your plan

    Not all platforms accept all plans. Verify before signing up that the service can bill your specific insurer. Ask about membership fees on top of insurance billing.

  3. 3

    Complete your clinical evaluation

    Your provider needs to document BMI ≥30 (or ≥27 with a weight-related comorbidity) and prior diet/exercise attempts. Come prepared with your medical history.

  4. 4

    Let your provider handle prior authorization

    The best services submit PA documentation on your behalf. This typically takes 7–30 days for an initial decision. Ask your provider about their average approval timeline.

  5. 5

    Appeal if denied — don't give up

    First-level appeals succeed often enough to be worth pursuing. Services like Sequence and FORM Health handle appeals as part of their program. If internal appeals fail, request an external independent review.

Related Resources

Best GLP-1 Providers That Accept Insurance

Detailed rankings with scores — our full evaluation of every provider's insurance navigation capabilities.

Best GLP-1 Programs Without Insurance

Self-pay options ranked by all-in cost if insurance coverage isn't available for your situation.

Cheapest GLP-1 Providers

Lowest-cost programs regardless of insurance status — compounded and brand-name options compared.

Best GLP-1 Without Prior Authorization

Skip the prior auth process entirely with self-pay programs that ship medication fast.

Insurance & GLP-1 Telehealth FAQs

Several telehealth platforms now accept insurance for brand-name GLP-1 medications like Wegovy, Zepbound, Mounjaro, and Ozempic. Sequence, FORM Health, PlushCare, Calibrate, and Found all support insurance billing in various capacities. The key differentiator is how much prior-authorization support each service provides. See our full insurance provider rankings for detailed scores.
Coverage varies by plan. As of 2026, Medicare Part D covers Wegovy and Zepbound for qualifying obesity diagnoses. Approximately 60% of large employer commercial plans cover at least one GLP-1 medication. Medicaid coverage varies by state. Your plan's formulary — not the telehealth service — determines whether medication is covered. The telehealth service's role is to submit the clinical documentation and prior authorization that maximizes your approval odds.
Prior authorization (PA) is a requirement from your insurer that your doctor submit clinical documentation proving medical necessity before they approve coverage for a GLP-1 medication. Standard PA requirements include a BMI ≥30 (or ≥27 with a weight-related comorbidity), documentation of prior diet and exercise attempts, and sometimes proof of step therapy with less expensive options. The quality of your provider's documentation directly affects approval rates — which is why choosing a telehealth service with strong PA support matters.
Insurance-covered programs prescribe brand-name FDA-approved medications (Wegovy, Zepbound, Mounjaro, Ozempic) and bill your insurer. Out-of-pocket cost with good coverage can be $0–$50/month for the medication itself, plus any program membership fee. Self-pay programs typically prescribe compounded semaglutide or tirzepatide at $199–$399/month all-in — no insurance needed, but no insurance savings either. If you have coverage, the insurance route is almost always cheaper. If you don't, see our best self-pay options.
Yes. Medicare Part D now covers Wegovy and Zepbound for patients with an obesity diagnosis. Telehealth platforms like Calibrate and Sequence have specific experience with Medicare prior authorization documentation. The Medicare Bridge program launching July 2026 may further expand access at a $50/month copay. Choose a provider experienced in Medicare-specific documentation requirements for the best approval odds.
Five things matter most: (1) Insurance acceptance — does the platform bill your specific plan? (2) Prior authorization support — do they submit PA and handle appeals, or leave it to you? (3) Clinical credentials — obesity medicine specialists produce stronger documentation for insurers. (4) Membership fees — some charge $0–$20/month, others $99–$249/month on top of insurance copays. (5) Formulary guidance — do they know which medication your plan prefers and prescribe accordingly?
Appeal immediately. First-level appeal success rates are meaningful — many initial denials are overturned with better documentation. The best telehealth services (Sequence, FORM Health) handle appeals as part of their service. If the internal appeal fails, you have the right to an external independent review. Some patients switch to a different GLP-1 medication that has better formulary placement with their plan. As a last resort, compounded self-pay programs remain an option while you pursue appeals.
No. Insurance covers only brand-name FDA-approved medications — Wegovy, Ozempic, Zepbound, and Mounjaro. Compounded semaglutide and tirzepatide are not eligible for insurance reimbursement. If your goal is to use insurance, you need a provider that prescribes brand-name medications and supports the prior authorization process.